These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10215181)

  • 21. Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3'-iminodipropionitrile in male rats.
    Nace CG; Genter MB; Sayre LM; Crofton KM
    Fundam Appl Toxicol; 1997 Jun; 37(2):131-40. PubMed ID: 9242586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The toxicity of IDPN on the vestibular system of the rat: new insights on its effects on behavior and neurofilament transport.
    Llorens J; Demêmes D; Sans A
    Neurotoxicology; 1994; 15(3):643-7. PubMed ID: 7854601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the effects of N-hydroxy-IDPN on the auditory, vestibular, and olfactory systems in rats.
    Crofton KM; Zhao X; Sayre LM; Genter MB
    Neurotoxicol Teratol; 1996; 18(3):297-303. PubMed ID: 8725642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and pathological effects in the rat define two groups of neurotoxic nitriles.
    Boadas-Vaello P; Riera J; Llorens J
    Toxicol Sci; 2005 Dec; 88(2):456-66. PubMed ID: 16150883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hair cell degeneration resulting from 3,3'-iminodipropionitrile toxicity in the rat vestibular epithelia.
    Llorens J; Demêmes D
    Hear Res; 1994 Jun; 76(1-2):78-86. PubMed ID: 7928719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-L-alanine and 3,3'-iminodipropionitrile.
    Dawson R; Marschall EG; Chan KC; Millard WJ; Eppler B; Patterson TA
    Neurotoxicol Teratol; 1998; 20(2):181-92. PubMed ID: 9536463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
    Ogawa N; Mizukawa K; Haba K; Sato H
    Eur Neurol; 1990; 30 Suppl 1():31-40. PubMed ID: 1968833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium benzoate attenuates iminodipropionitrile-induced behavioral syndrome in rats.
    Tariq M; Khan HA; Al Moutaery K; Al Deeb S
    Behav Pharmacol; 2004 Dec; 15(8):585-8. PubMed ID: 15577457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine.
    Cadet JL; Taylor E; Freed WJ
    Pharmacol Biochem Behav; 1988 Feb; 29(2):381-5. PubMed ID: 2452450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of behavioral, vestibular, and axonal effects of subchronic IDPN in the rat.
    Llorens J; Rodríguez-Farré E
    Neurotoxicol Teratol; 1997; 19(2):117-27. PubMed ID: 9136128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IDPN-induced monoamine and hydroxyl radical changes in the rat brain.
    Wakata N; Araki Y; Sugimoto H; Iguchi H; Kinoshita M
    Neurochem Res; 2000 Mar; 25(3):401-4. PubMed ID: 10761986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of P450 inhibition and induction on the olfactory toxicity of beta,beta'-iminodipropionitrile (IDPN) in the rat.
    Genter MB; Deamer NJ; Cao Y; Levi PE
    J Biochem Toxicol; 1994 Feb; 9(1):31-9. PubMed ID: 8151630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-lasting effect of ceruletide on dyskinesia and monoaminergic neuronal pathways in rats treated with iminodipropionitrile.
    Ogawa N; Haba K; Asanuma M; Mori A
    Brain Res; 1991 Aug; 556(2):271-9. PubMed ID: 1933361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distal effects in a model of proximal axonopathy: 3,3'-iminodipropionitrile causes specific loss of neurofilaments in rat vestibular afferent endings.
    Seoane A; Demêmes D; Llorens J
    Acta Neuropathol; 2003 Nov; 106(5):458-70. PubMed ID: 12898157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of location, severity, and dose response of proximal axonal lesions induced by 3,3'-iminodipropionitrile and deuterium substituted analogs.
    Denlinger RH; Anthony DC; Amarnath V; Graham DG
    J Neuropathol Exp Neurol; 1992 Nov; 51(6):569-76. PubMed ID: 1484287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of iminodipropionitrile on cerebral amino acid levels.
    Toth E; Lajtha A; Vizi ES
    Brain Res Bull; 1997; 44(6):715-8. PubMed ID: 9421135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of selenium on iminodipropionitrile-induced toxicity.
    al-Deeb S; al-Moutaery K; Bruyn GW; Tariq M
    J Psychiatry Neurosci; 1995 May; 20(3):189-92. PubMed ID: 7786879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional neurochemical studies on the effect of beta, beta'-iminodipropionitrile (IDPN) in the rat.
    Langlais PJ; Huang PC; Gabay S
    J Neurosci Res; 1975; 1(5-6):419-35. PubMed ID: 1241588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of neurotoxic action of beta,beta'-iminodipropionitrile (IDPN): N-hydroxylation enhances neurotoxic potency.
    Morandi A; Gambetti P; Arora PK; Sayre LM
    Brain Res; 1987 Dec; 437(1):69-76. PubMed ID: 3427483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of 3,3'-iminodipropionitrile and deuterium-substituted analogs: potential mechanisms of detoxification and activation.
    Denlinger RH; Anthony DC; Amarnath K; Amarnath V; Graham DG
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):59-66. PubMed ID: 8291062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.